Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a stylized letter "A" placed to the left of the term "AEON".
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
944 x 250
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
AEON Biopharma, Inc.
*STREET
4040 MacArthur Blvd., Suite 260
*CITY
Newport Beach
*STATE
(Required for U.S. applicants)
California
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92660
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for the treatment of neurological conditions; Pharmaceutical preparations for the treatment of gastrointestinal
conditions; Pharmaceutical preparations for the treatment of neurologic and psychiatric disorders; botulinum toxins for therapeutic use.
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88626890
Filing Date:09/23/2019
To the Commissioner for Trademarks:
MARK: AEON (stylized and/or with design, see mark)
The literal element of the mark consists of AEON. The mark consists of a stylized letter "A" placed to the left of the term "AEON".
The applicant, AEON Biopharma, Inc., a corporation of Delaware, having an address of
4040 MacArthur Blvd., Suite 260
Newport Beach, California 92660
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for the treatment of neurological conditions; Pharmaceutical preparations for the treatment of gastrointestinal conditions; Pharmaceutical
preparations for the treatment of neurologic and psychiatric disorders; botulinum toxins for therapeutic use.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant hereby appoints Louis C. Cullman. Other appointed attorneys are Alexis Crawford Douglas. Louis C. Cullman of K&L Gates LLP, is a member of the XX bar, admitted to the bar in
XXXX, bar membership no. XXX, and the attorney(s) is located at
1 Park Plaza, 12th Floor
Irvine, California 92614
United States
312-807-4346(phone)
312-345-9980(fax)
OCtrademarks@klgates.com (authorized).
Louis C. Cullman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the
email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Scott Akamine/ Date: 09/23/2019
Signatory's Name: Scott Akamine
Signatory's Position: General Counsel
Payment Sale Number: 88626890
Payment Accounting Date: 09/23/2019
Serial Number: 88626890
Internet Transmission Date: Mon Sep 23 13:23:29 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.X-20190923132329531
039-88626890-6103d794764d4ed80576ab6295a
432e43ae83aa087b79a2851def1e6b53b87142a-
DA-23292170-20190920165343134552